Skip to main content

UFS is Currently a Strong Dividend Investment

$UFS is a good dividend investment


Domtar Corp. engages in the design, manufacturing, marketing, and distribution of fiber-based products, which includes communication papers, specialty and packaging papers and absorbent hygiene products. It operates through the following segments: Pulp and Paper, and Personal Care. The Pulp and Paper segment is involved in the design, manufacturing, marketing, and distribution of communication, specialty and packaging papers, as well as softwood, fluff, and hardwood market pulp. The Personal Care segment consists of the design, manufacturing, marketing, and distribution of absorbent hygiene products. The company was founded on March 7, 2007 and is headquartered in Fort Mill, SC.

Founded: 2007

Number of Employees: 10,000

Analysis Framework

We looked for industrial stocks with a dividend yield between 3.69% and 9.6% and found 70.  Out of that 70 we removed any that had not increased their dividend each year for the past five years.  That left a portfolio of 21 stocks.  We then ran three analyses on the group: dividend coverage, value and total dividend return.

Results

Dividend Coverage

We were looking for dividends to be less than 75% of free cash flow.  UFS was technically the only one that qualified, although TCP was close at 76%.

Value

There are many ways we could look at value, but since this is a dividend analysis, we'll consider a stock to be relatively undervalued if its forward dividend yield is higher than the average of the past five years.

UFS  has a forward dividend yield 28% higher than its average.  With a forward yield of 5.21%, it's also currently above highest dividend yield for the past five years.

Total Return

This number is an estimate comprised of the sum of the forward dividend yield and the 5 year historical dividend growth rate.

UFS has an appealing total return of 16%.

Conclusion

We like UFS as a dividend investment.  Although the initial cutoff for the portfolio was 5 years of year over year dividend growth, UFS has actually had 10 years.

Disclaimer

Whether or not this stock is appropriate for your portfolio, risk profile and long-term goals is not part of this evaluation.  The consequences of your investment decisions are yours and yours alone.  INVRS, its parent company, directors, officers and employees cannot be held responsible for any investment decisions you make.
Labels:

Comments

Post a Comment

Popular posts from this blog

11 Reasons Why INVRS is Better Than Excel Alone

If you work with your own investment models you likely use excel to build them, but excel isn’t ideal for many reasons and it costs you in other ways.   First, you need good data and it isn’t just lying around in an easy to import format.   You’re either keying it in yourself or paying money for excel downloads.   When you need data from numerous sources – price information, data from different statements and across multiple years - you must merge it from multiple sheets.   It's a n inefficient process which can lead to data corruption. After all this data is collected and merged, models built and tested, the net result is one statistic for one company.   A stand-alone number without context has limited use.   To be meaningful, you need to compare it to similar companies.       This is just a sample of the challenges.  You need software that overcomes these problems and is designed for investment model creation. Surprise!  This software exists,
Post a Comment
Read more

NextEra - Good Dividend in the Renewable Energy Sector

NextEra had good results relative to a group of peers in a factor-based analysis. NextEra has an appealing profitability and income profile. Its price momentum looks decent, with a caveat. Its relatively small size (a small mid-cap) coupled with its industry (renewable energy) further weight the odds that this company could be a strong performer in the future. If you want in on renewable energy, we recommend NextEra. The Analysis Overview I created a portfolio of stocks in the alternative energy sector, looking specifically for companies with a market cap over $1B but less than $4B.  This is a sweet spot that offers strong potential for growth but is also substantial enough not to be too speculative. It's my believe that alternative energy is on the ascendance, where as fossil fuels will inevitably decline (NextEra isn't a pure play in this regard however, natural gas assets are part of its portfolio).  If you share this belief and you want exposure to this ma
Post a Comment
Read more

GlaxoSmithKline Scores High in Quality

I created a portfolio of the top pharmaceutical companies trading in the US and ran a quality of earnings analysis on them.  With the highest possible score being nine, GSK scored the best with seven. Here are the results: Quality of Earnings - Major Pharmaceuticals Here's the balance of the companies in the portfolio.  We can see that AZN was the worst at two. Quality of Earnings - Major Pharmaceuticals 2 Just for laughs, lets see how GSK and AZN have performed from a price perspective. Interestingly, AZN has been outperforming GSK. It'll be interesting to say if this trend will continue or if it will, more correctly I believe, reverse.
Post a Comment
Read more